Optimising treatment of erectile dysfunction with avanafil, a highly selective second-generation phosphodiesterase type 5 inhibitor

A recent webinar on Men’s Health featured the use of avanafil – a second-generation phosphodiesterase type 5 inhibitor (PDE5i) for the treatment of erectile dysfunction (ED). The webinar was jointly organised by A. Menarini together with the Malaysian Medical Association and Malaysian Pharmacists Society.